Instituto Tecnologico y de Estudios Superiores de Monterey Report issue

Academic/Hospital Phase 3

Organization Overview

First Clinical Trial
2013
NCT01909336
First Marketed Drug
None
First NDA Approval
None
Last Known Activity
2021

Timeline

NOW
  • Now

Alternative names

Instituto Tecnologico y de Estudios Superiores de Monterey

Active Ingredients

Drugs in Phase 3 Trials (2)

glucose monohydrate (1 trial)

sodium chloride (1 trial)

Drugs in Other Trials (2)

zinc (1 trial)

zinc amino acid complex (1 trial)

Indications

Experimental Indications (Clinical Trials, Phases 1-4)


 

Hyponatremia (Phase 3)

Overview

  • Highest Phase: Phase 3
  • # of Trials: 2
  • # of Trial APIs: 4